DiaMonTech AG Stock

Biotechnology & Medical Research

Days

Hours

Minutes

Seconds

-40%

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

News in other languages: DiaMonTech AG

19-11-26	DiaMonTech : verschiebt Börsengang
19-11-25	DiaMonTech : DAK-Gesundheit und DiaMonTech planen strategische Zusammenarbeit im Bereich der nicht-invasiven Blutzuckermessung für neue Behandlungsstrategien im Bereich Diabetes

More news

Managers and Directors: DiaMonTech AG

Manager	Title	Age	Since
Werner Mäntele CTO	Chief Tech/Sci/R&D Officer	-	2015-01-09
Thorsten Lubinski CEO	Chief Executive Officer	52	2015-03-31
Enrico Just DFI	Director of Finance/CFO	-	2019-09-30

More insiders

DiaMonTech AG is a Germany-based medical device company. It develops a device for non-invasive measuring of glucose levels in diabetes patients. The device is based on spectroscopy and uses photothermal detection technology. The device range under development includes a desktop device for clinical settings and multiple users, as well as a compact pocket device for the end user.

Employees

Sector

Biotechnology & Medical Research

More about the company

25-09-15	DiaMonTech AG announced that it has received ?8 million in funding from Samsung NEXT, LLC	CI
24-11-25	DiaMonTech AG announced that it has received funding from Disrupt Health Impact Fund	CI
23-12-06	DiaMonTech AG announced that it has received funding from Moll Family GmbH, and other investors	CI
22-02-16	DiaMonTech AG announced that it has received $5 million in funding from IBB Beteiligungsgesellschaft mbH, Unorthodox Ventures, Samsung Venture Investment Corporation	CI
19-11-26	DiaMonTech AG has withdrawn its IPO in the amount of €59.375 million.	CI
19-11-25	DAK-Gesundheit and DiaMonTech AG Plan Strategic Cooperation in the Non-Invasive Blood Glucose Monitoring Sector for New Treatment Strategies in the Diabetes Sector	CI
19-11-13	DiaMonTech AG has filed an IPO in the amount of €59.375 million.	CI
19-11-11	DiaMonTech AG Signs A Further Agreement with an International Sales Company	CI
19-10-21	DiaMonTech GmbH Publishes Results of Clinical Study Confirming the Accuracy of its Non-Invasive Blood Glucose-Monitoring Technology	CI
19-10-01	DiaMonTech GmbH Appoints Enrico Just as Managing Director and CFO	CI
19-09-16	Deutscher Apothekerverband e. V. & DiaMonTech GmbH Intends Strategic Cooperation to Significantly Improve the Care of Diabetes Patients and to Take an Innovative Step into the Future	CI
19-09-08	DiaMonTech GmbH announced that it has received €7 million in funding from IBB Beteiligungsgesellschaft mbH, Bioventure Consulting GmbH, and other investors	CI
18-09-04	DiaMonTech GmbH announced that it has received funding from IBB Beteiligungsgesellschaft mbH, Macnica, Inc., Jindong Investment Group Co., Ltd.	CI

19-11-26	DiaMonTech : postpones IPO	EQ
19-11-25	DiaMonTech AG: DAK-Gesundheit and DiaMonTech plan strategic cooperation in the non-invasive blood glucose monitoring sector for new treatment strategies in the diabetes sector	EQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DIAMONTECH AG	-.--%	-.--%	-	-	0
MIMEDX GROUP, INC.	+0.54%	0.00%	-38.74%	-35.65%	548M
ROKIT HEALTHCARE INC.	+0.40%	+7.76%	+257.55%	-	528M
NIBEC CO., LTD.	-0.42%	+7.97%	-33.02%	+25.47%	142M
BONUS BIOGROUP LTD.	-5.14%	-15.95%	+48.99%	+85.53%	125M
Average	-0.92%	-1.98%	+58.69%	+25.12%	335.96M
Weighted average by Cap.	-0.15%	-0.51%	+86.54%	-6.39%

DiaMonTech AG Stock

Stocks

Biotechnology & Medical Research

Latest news : DiaMonTech AG

Press Releases: DiaMonTech AG

News in other languages: DiaMonTech AG

Managers and Directors: DiaMonTech AG

Bio Medical Devices

Company Profile